COMMUNIQUÉS West-GlobeNewswire

Allscripts Names Dennis Olis Chief Financial Officer
31/01/2018
CHICAGO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX ) announced Dennis Olis has been named Chief Financial Officer of the Company, effective January 31, 2018. Since May of 2017 [...]
Nuvectra™ Announces Proposed Follow-On Stock Offering
31/01/2018
PLANO, Texas, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that it is commencing an underwritten follow-on public offering of its [...]
Agios to Webcast Conference Call of Fourth Quarter and Full Year 2017 Financial Results on February 14, 2018
31/01/2018
CAMBRIDGE, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company [...]
Gemphire Announces Initiation of Phase 2a Clinical Trial of Gemcabene in Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD)
31/01/2018
Pediatric NAFLD/NASH is a large and untreated market; provides an opportunity to advance gemcabene in an underserved area with millions of affected patients Proof-of-concept clinical trial expands company’s [...]
AIT Therapeutics Announces Completion of the Agreement to License the Revolutionary Nitric Oxide (NO) Generator and Delivery System
31/01/2018
First Regulatory Filing for the eNOGenerator System Expected By End of 2018 NEW YORK, Jan. 31, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing [...]
IACT Health Selects Alpha Clinical Systems ACS360 eSource Platform for Clinical Trial Data Capture
31/01/2018
COLUMBUS, Ga. and PISCATAWAY, N.J., Jan. 31, 2018 (GLOBE NEWSWIRE) -- IACT Health, a clinical trial management company dedicated to streamlining study operations for highly efficient clinical trials, and Alpha Clinical [...]
Bavarian Nordic Announces the Planned Departure of Chief Financial Officer, Ole Larsen
31/01/2018
COPENHAGEN, Denmark, January 31, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that Ole Larsen, Executive Vice President and Chief Financial Officer will depart from the Company to pursue new [...]
NAPA’s Linda Shore-Lesserson Leads Study Recommending Concise Guidelines for Anticoagulation during Cardiopulmonary Bypass Surgery
31/01/2018
MELVILLE, N.Y., Jan. 31, 2018 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia announced today that one of its leading anesthesiologists, Linda Shore-Lesserson, MD, served as the lead author on an innovative [...]
Catalyst Biosciences to Present Multi-Dose Subcutaneous Data for CB 2679d in Individuals with Hemophilia B in an Oral Presentation at the 11th Annual Congress of EAHAD
31/01/2018
Pharmacokinetics and activity after daily dosing with high potency FIX variant will be reported Conference call and webcast for investment community to be held Feb. 9, 2018 at 8:30 a.m. EST SOUTH SAN FRANCISCO, Calif., [...]
DXS International plc : Half-year Report
31/01/2018
DXS INTERNATIONAL PLC HALF YEAR REPORT DXS International plc ("DXS" or "the Company"), the NEX Growth Market quoted healthcare information and clinical decision support systems provider today announces its half year [...]
HCi Viocare to Develop Proprietary Blockchain Based System for Handling Client Records and Sensing-Technology Data
31/01/2018
GLASGOW, Scotland, Jan. 31, 2018 (GLOBE NEWSWIRE) -- HCi Viocare (OTCQB: VICA) is pleased to announce that its management, acknowledging the tremendous advantages of Blockchain technology, has decided to develop its own [...]
TOMI Environmental Solutions, Inc. Appoints Dr. Boh Soon Lim to Serve on Board of Directors
31/01/2018
BEVERLY HILLS, Calif., Jan. 31, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, [...]
Immuron Enrols First Patients in Clinical Study of IMM-529 for Treatment of Clostridium Difficile Infection (CDI)
31/01/2018
Key Highlights: First patients enrolled in Immuron’s IMM-529 clinical study at Hadassah Medical Center in Israel Trial will treat 60 confirmed patients over 28 days to evaluate safety and efficacy of IMM-529 for the [...]
PositiveID’s FireflyDX Prototype Detects Flu Types; Chief Science Officer Explains Why Accurate Flu Detection at Point of Care Enables Smart Treatment Decisions in Interview with SmallCapVoice.com
31/01/2018
AUSTIN, Texas, Jan. 31, 2018 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. today announced it conducted a new audio interview with PositiveID Corporation (“PositiveID” or the “Company”) (OTC:PSID), a life sciences company [...]
Biodesix Announces PD-L1 Collaboration with Professor Fred R. Hirsch
31/01/2018
BOULDER, Colo., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Biodesix ® announced a new collaboration agreement with PD-L1 expert Professor Fred R. Hirsch, MD, PhD, laboratory director at the Hirsch Biomarker Laboratory at the [...]
Tower One Completed Five Additional Towers
31/01/2018
VANCOUVER, British Columbia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (the “Company ”) announces that it has completed five additional towers in Argentina. An [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself
31/01/2018
FIT Biotech Oy Company release January 31, 2018 at 3.30 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]
BriaCell Update: Early Evidence of Efficacy and Safety of Bria-IMT™
31/01/2018
BERKELEY, Calif. and VANCOUVER, British Columbia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]
Acer Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
31/01/2018
NEWTON, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]

Pages